(INVZ) Innoviz Technologies - Ratings and Ratios
Solid-State LiDAR, Long-Range LiDAR, Short-Range LiDAR, Perception Software
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 79.0% |
| Value at Risk 5%th | 106% |
| Relative Tail Risk | -18.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.08 |
| Alpha | -66.28 |
| CAGR/Max DD | -0.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.439 |
| Beta | 1.844 |
| Beta Downside | 1.804 |
| Drawdowns 3y | |
|---|---|
| Max DD | 91.60% |
| Mean DD | 68.61% |
| Median DD | 72.41% |
Description: INVZ Innoviz Technologies October 27, 2025
Innoviz Technologies Ltd. (NASDAQ: INVZ) designs and manufactures automotive-grade solid-state LiDAR sensors and accompanying perception software aimed at enabling mass-scale autonomous driving. Its product lineup includes the InnovizOne sensor for automakers and robotaxi fleets, the InnovizTwo Long-Range and Short-to-Mid-Range variants for higher-performance use cases, and a software suite that converts raw point-cloud data into actionable perception outputs. The company sells globally-covering Europe, APAC, the Middle East, Africa, Israel, and North America-through a mix of direct sales and distribution partners, and is headquartered in Rosh HaAyin, Israel.
Key industry metrics that shape Innoviz’s growth prospects include a projected 22 % CAGR for the automotive LiDAR market through 2030 (according to IDTechEx) and an estimated total addressable market of roughly $12 billion for solid-state LiDAR in passenger vehicles. In its most recent quarterly filing (Q2 2024), Innoviz reported a 48 % year-over-year increase in revenue, driven largely by new supply agreements with a major European OEM and a pilot deployment with a leading robotaxi operator in the United States. The firm’s gross margin improved to 38 % after scaling production volumes, reflecting the cost advantages of its silicon-photonic architecture.
For a deeper, data-driven assessment of Innoviz’s valuation and risk profile, you may find ValueRay’s analytical tools useful for independent research.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-65.1m TTM) > 0 and > 6% of Revenue (6% = 2.91m TTM) |
| FCFTA -0.40 (>2.0%) and ΔFCFTA 12.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 144.7% (prev 207.4%; Δ -62.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.37 (>3.0%) and CFO -56.6m > Net Income -65.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (203.4m) change vs 12m ago 21.25% (target <= -2.0% for YES) |
| Gross Margin 23.49% (prev -12.00%; Δ 35.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.79% (prev 22.97%; Δ 9.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -45.43 (EBITDA TTM -60.0m / Interest Expense TTM 1.45m) >= 6 (WARN >= 3) |
Altman Z'' -29.98
| (A) 0.46 = (Total Current Assets 102.2m - Total Current Liabilities 32.1m) / Total Assets 151.1m |
| (B) -5.14 = Retained Earnings (Balance) -776.6m / Total Assets 151.1m |
| warn (B) unusual magnitude: -5.14 — check mapping/units |
| (C) -0.44 = EBIT TTM -65.6m / Avg Total Assets 147.7m |
| (D) -12.65 = Book Value of Equity -776.6m / Total Liabilities 61.4m |
| Total Rating: -29.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 36.99
| 1. Piotroski 1.50pt |
| 2. FCF Yield -36.65% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.39 |
| 5. Debt/Ebitda -0.45 |
| 6. ROIC - WACC (= -82.77)% |
| 7. RoE -70.52% |
| 8. Rev. Trend 83.53% |
| 9. EPS Trend 85.94% |
What is the price of INVZ shares?
Over the past week, the price has changed by -19.17%, over one month by -21.82%, over three months by -43.89% and over the past year by -46.72%.
Is INVZ a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the INVZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.7 | 178.9% |
| Analysts Target Price | 2.7 | 178.9% |
| ValueRay Target Price | 0.7 | -30.5% |
INVZ Fundamental Data Overview December 25, 2025
P/S = 4.2505
P/B = 2.2963
Beta = 1.404
Revenue TTM = 48.4m USD
EBIT TTM = -65.6m USD
EBITDA TTM = -60.0m USD
Long Term Debt = 35.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 5.75m USD (from shortTermDebt, last quarter)
Debt = 35.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 27.1m USD (from netDebt column, last quarter)
Enterprise Value = 166.5m USD (205.9m + Debt 35.0m - CCE 74.4m)
Interest Coverage Ratio = -45.43 (Ebit TTM -65.6m / Interest Expense TTM 1.45m)
FCF Yield = -36.65% (FCF TTM -61.0m / Enterprise Value 166.5m)
FCF Margin = -126.0% (FCF TTM -61.0m / Revenue TTM 48.4m)
Net Margin = -134.5% (Net Income TTM -65.1m / Revenue TTM 48.4m)
Gross Margin = 23.49% ((Revenue TTM 48.4m - Cost of Revenue TTM 37.1m) / Revenue TTM)
Gross Margin QoQ = 15.04% (prev 16.00%)
Tobins Q-Ratio = 1.10 (Enterprise Value 166.5m / Total Assets 151.1m)
Interest Expense / Debt = 4.13% (Interest Expense 1.45m / Debt 35.0m)
Taxrate = -0.22% (negative due to tax credits) (34.0k / -15.4m)
NOPAT = -65.8m (EBIT -65.6m * (1 - -0.22%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 3.18 (Total Current Assets 102.2m / Total Current Liabilities 32.1m)
Debt / Equity = 0.39 (Debt 35.0m / totalStockholderEquity, last quarter 89.7m)
Debt / EBITDA = -0.45 (negative EBITDA) (Net Debt 27.1m / EBITDA -60.0m)
Debt / FCF = -0.44 (negative FCF - burning cash) (Net Debt 27.1m / FCF TTM -61.0m)
Total Stockholder Equity = 92.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -43.12% (Net Income -65.1m / Total Assets 151.1m)
RoE = -70.52% (Net Income TTM -65.1m / Total Stockholder Equity 92.4m)
RoCE = -51.54% (EBIT -65.6m / Capital Employed (Equity 92.4m + L.T.Debt 35.0m))
RoIC = -71.22% (negative operating profit) (NOPAT -65.8m / Invested Capital 92.4m)
WACC = 11.55% (E(205.9m)/V(240.9m) * Re(12.81%) + D(35.0m)/V(240.9m) * Rd(4.13%) * (1-Tc(-0.00)))
Discount Rate = 12.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 11.00%
Fair Price DCF = unknown (Cash Flow -61.0m)
EPS Correlation: 85.94 | EPS CAGR: 24.14% | SUE: 0.0 | # QB: 0
Revenue Correlation: 83.53 | Revenue CAGR: 80.89% | SUE: 0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=+0.013 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.28 | Chg30d=-0.035 | Revisions Net=+0 | Growth EPS=+4.6% | Growth Revenue=+45.1%
Additional Sources for INVZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle